These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18461312)

  • 1. The immunogenetics of multiple sclerosis.
    Svejgaard A
    Immunogenetics; 2008 Jun; 60(6):275-86. PubMed ID: 18461312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
    Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
    Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
    Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
    Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.
    González-Enríquez GV; Torres-Mendoza BM; Márquez-Pedroza J; Macías-Islas MA; Ortiz GG; Cruz-Ramos JA
    Immunogenetics; 2018 Aug; 70(8):547-551. PubMed ID: 29397401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.
    Zipp F; Windemuth C; Pankow H; Dichgans J; Wienker T; Martin R; Müller C
    Hum Immunol; 2000 Oct; 61(10):1021-30. PubMed ID: 11082515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients.
    Amirzargar A; Mytilineos J; Yousefipour A; Farjadian S; Scherer S; Opelz G; Ghaderi A
    Eur J Immunogenet; 1998 Aug; 25(4):297-301. PubMed ID: 9777330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA-class II DQA1, DQB1, DRB1 and DPB1 in Italian multiple sclerosis patients.
    Ciusani E; Allen M; Sandberg-Wollheim M; Eoli M; Salmaggi A; Milanese C; Nespolo A; Gyllensten U
    Eur J Immunogenet; 1995 Apr; 22(2):171-8. PubMed ID: 7605774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
    Barcellos LF; Oksenberg JR; Begovich AB; Martin ER; Schmidt S; Vittinghoff E; Goodin DS; Pelletier D; Lincoln RR; Bucher P; Swerdlin A; Pericak-Vance MA; Haines JL; Hauser SL;
    Am J Hum Genet; 2003 Mar; 72(3):710-6. PubMed ID: 12557126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
    Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
    PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of HLA-DRB1 and DQA1 genes and of the amino acid polymorphisms in the functional domain of DR beta 1 chain in multiple sclerosis.
    Ghabanbasani MZ; Gu XX; Spaepen M; Vandevyver C; Raus J; Marynen P; Carton H; Cassiman JJ
    J Neuroimmunol; 1995 Jun; 59(1-2):77-82. PubMed ID: 7797622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.
    Marrosu MG; Murru R; Murru MR; Costa G; Zavattari P; Whalen M; Cocco E; Mancosu C; Schirru L; Solla E; Fadda E; Melis C; Porru I; Rolesu M; Cucca F
    Hum Mol Genet; 2001 Dec; 10(25):2907-16. PubMed ID: 11741834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.
    Quelvennec E; Bera O; Cabre P; Alizadeh M; Smadja D; Jugde F; Edan G; Semana G
    Tissue Antigens; 2003 Feb; 61(2):166-71. PubMed ID: 12694585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
    Haegert DG; Swift FV; Benedikz J
    Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles.
    Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U
    Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis.
    Celius EG; Harbo HF; Egeland T; Vartdal F; Vandvik B; Spurkiand A
    J Neurol Sci; 2000 Sep; 178(2):132-5. PubMed ID: 11018705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
    Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
    Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.